Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

AIM WINNERS & LOSERS: TomCo raises funds; Instem bid "final"

Fri, 13th Oct 2023 10:53

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

TomCo Energy PLC, up 19% at 0.065 pence, 12-month range 0.050-0.54p. The US-focused oil development firm raises gross proceeds of GBP100,000 via a subscription of 125.0 million shares at 0.08p each - a 46% premium to Thursday's closing price of 0.055p. Says subscription is within existing shareholder, and shares represent around 3.9% of its enlarged share capital. Will use funds cover costs of developing Tar Sands Holdings II in Utah, via its Greenfield Energy subsidiary.

----------

Ondine Biomedical Inc, up 10% at 8.00p, 12-month range 6.86p-29.19p. The Vancouver-based life sciences company says its Steriwave technology is now available in hospitals across Canada, with Nova Scotia's largest hospital Queen Elizabeth II Health Sciences Centre in Nova Scotia now becoming the latest facility to implement the spray. Steriwave employs patented nasal photodisinfection technology to eliminate bacteria, fungi and viruses located on human tissues. "It is hugely satisfying that Steriwave is now available in hospitals from coast to coast across Canada, giving patients enhanced protection against post-surgical infections," says CEO Carolyn Cross.

----------

AIM - LOSERS

----------

Instem PLC, down 6.9% at 761.50p, 12-month range 580p-835.56p. Specialist healthcare industry investor Archimed SAS confirms its final offer for the life sciences IT company is 833p per share, valuing Instem at just over GBP200 million. The offer will not be increased, Archimed says. Instem had agreed to the private equity buyout at the end of August. The court and general meetings to approve the deal are scheduled for next Thursday.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
8 May 2024 16:27

TRADING UPDATES: Hellenic Dynamics and Ondine Biomedical raise funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

3 May 2024 12:11

Ondine Biomedical shares rise on fundraise to advance Steriwave

(Alliance News) - Ondine Biomedical Inc shares were up on early Friday afternoon, after the company announced plans to conduct a fundraise to support ...

24 Apr 2024 16:02

EARNINGS AND TRADING: Nichols trading in line; Ondine revenue doubles

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

24 Apr 2024 15:09

Ondine reports significant financial growth

(Sharecast News) - Ondine Biomedical reported significant growth in a trading update on Wednesday, with revenues doubling to $1.2m in 2023, driven by ...

22 Apr 2024 12:04

Ondine Biomedical celebrates use of Steriwave in Australian hospital

(Alliance News) - Ondine Biomedical Inc on Monday announced that Steriwave has been used for the first time in an Australian hospital.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.